First-Of-Its-Kind Prostate Cancer Imaging Agent Approved By FDA
Executive Summary
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.